Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery

Starting soon

Conditions studied: Prostate Cancer

In brief

This study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasibility and value in clinical application.

Key facts

Study ID

NCT07690462

Run by

Xiangya Hospital of Central South University

People needed

120

Starts

2026-07-01

Expected to finish

2027-12-01

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• All adult male patients who are scheduled to undergo prostate biopsy at the Department of Urology, Xiangya Hospital due to clinical suspicion (e.g., elevated PSA, abnormal digital rectal examination, or suspicious lesions on imaging).
• Patients whose cardiac, pulmonary, hepatic, renal, and coagulation functions are essentially normal and who are able to tolerate the biopsy procedure.
• The patient or their legally authorized representative has signed the written informed consent form.

You may not qualify if…

• Patients in the acute infection phase or febrile period.
• Patients with severe bleeding tendency conditions who are unable to undergo biopsy.
• Patients with any serious concomitant disease that, in the investigator's opinion, may interfere with the study results or increase the patient's risk (e.g., hypertensive crisis; decompensated cardiac insufficiency; severe internal or external hemorrhoids, perianal or rectal lesions, etc.).

Where it is running

• Xiangya Hospital Central South University — Changsha, Hunan, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.